A nearly 30-year study shows a strong long-term association between very high lipoprotein(a) levels and cardiovascular ...
Woman's World on MSN
Normal AST levels by age: Are you at risk of fatty liver disease?
A1C, LDL, HDL… the number of medical abbreviations you might see on your patient portal is enough to make you think your ...
Studies show that an LDL level at or below 100 milligrams per deciliter (mg/dL) is ideal for most adults. If you have a ...
Woman's World on MSN
Which statin is right for you? Compare meds with this handy intensity chart you'll want to save for future reference
If you have high cholesterol, there's a good chance your doctor has recommended statins to get your numbers back into a ...
What Is Lerochol, and Why Does It Matter? Lerochol (lerodalcibep-liga) is a new medicine approved by the FDA to help lower elevated levels of low-density lipoprotein cholesterol (LDL-C), often called ...
A new daily pill could reduce bad cholesterol levels by 60%, according to a new study. Enlicitide, which was developed by Merck, lowered “bad” LDL cholesterol by more than half in a global study ...
A new daily pill could reduce bad cholesterol levels by 60%, according to a new study. Enlicitide, which was developed by Merck, lowered "bad" LDL cholesterol by more than half in a global study ...
NEW ORLEANS — Lowering the level of low-density lipoprotein (LDL) cholesterol to below 40 mg/dL — well beneath current poststroke guideline targets — reduced major cardiovascular events without ...
Please provide your email address to receive an email when new articles are posted on . PCSK9 inhibition with alirocumab did not reduce the primary endpoint of coronary plaque progression. LDL levels ...
The daily pills are designed for use among those whose high cholesterol is not reaching healthy targets despite taking other medications. Thana Prasongsin via Getty Images An experimental pill ...
Altering a single gene may help people lower dangerously high levels of cholesterol and other fats in the blood, according to new research presented Saturday at the annual meeting of the American ...
In a step toward the wider use of gene editing, a treatment that uses Crispr successfully slashed high cholesterol levels in a small number of people. In a trial conducted by Swiss biotech company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback